Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4073407
Max Phase: Preclinical
Molecular Formula: C18H35N5
Molecular Weight: 321.51
Molecule Type: Small molecule
Associated Items:
ID: ALA4073407
Max Phase: Preclinical
Molecular Formula: C18H35N5
Molecular Weight: 321.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCNc1ccnc(NCCN(C)C)n1
Standard InChI: InChI=1S/C18H35N5/c1-4-5-6-7-8-9-10-11-13-19-17-12-14-20-18(22-17)21-15-16-23(2)3/h12,14H,4-11,13,15-16H2,1-3H3,(H2,19,20,21,22)
Standard InChI Key: ZUMMABQMAJHRGO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 321.51 | Molecular Weight (Monoisotopic): 321.2892 | AlogP: 4.00 | #Rotatable Bonds: 14 |
Polar Surface Area: 53.08 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.66 | CX LogP: 4.28 | CX LogD: 2.97 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.51 | Np Likeness Score: -1.04 |
1. Odell LR, Abdel-Hamid MK, Hill TA, Chau N, Young KA, Deane FM, Sakoff JA, Andersson S, Daniel JA, Robinson PJ, McCluskey A.. (2017) Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain., 60 (1): [PMID:27997171] [10.1021/acs.jmedchem.6b01422] |
Source(1):